The lineage-specific transcription factor CDX2 navigates dynamic chromatin to control distinct stages of intestine development.


Journal

Development (Cambridge, England)
ISSN: 1477-9129
Titre abrégé: Development
Pays: England
ID NLM: 8701744

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 25 09 2018
accepted: 30 01 2019
pubmed: 13 2 2019
medline: 31 12 2019
entrez: 13 2 2019
Statut: epublish

Résumé

Lineage-restricted transcription factors, such as the intestine-specifying factor CDX2, often have dual requirements across developmental time. Embryonic loss of CDX2 triggers homeotic transformation of intestinal fate, whereas adult-onset loss compromises crucial physiological functions but preserves intestinal identity. It is unclear how such diverse requirements are executed across the developmental continuum. Using primary and engineered human tissues, mouse genetics, and a multi-omics approach, we demonstrate that divergent CDX2 loss-of-function phenotypes in embryonic versus adult intestines correspond to divergent CDX2 chromatin-binding profiles in embryonic versus adult stages. CDX2 binds and activates distinct target genes in developing versus adult mouse and human intestinal cells. We find that temporal shifts in chromatin accessibility correspond to these context-specific CDX2 activities. Thus, CDX2 is not sufficient to activate a mature intestinal program; rather, CDX2 responds to its environment, targeting stage-specific genes to contribute to either intestinal patterning or mature intestinal function. This study provides insights into the mechanisms through which lineage-specific regulatory factors achieve divergent functions over developmental time.

Identifiants

pubmed: 30745430
pii: dev.172189
doi: 10.1242/dev.172189
pmc: PMC6432663
pii:
doi:

Substances chimiques

CDX2 Transcription Factor 0
CDX2 protein, human 0
Cdx2 protein, mouse 0
Chromatin 0
Homeodomain Proteins 0
Trans-Activators 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : F32 DK115080
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK085532
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085532
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK082889
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA190558
Pays : United States

Informations de copyright

© 2019. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing or financial interests.

Références

Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Genesis. 2004 Jul;39(3):186-93
pubmed: 15282745
Cell Rep. 2014 Oct 9;9(1):261-271
pubmed: 25263553
Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G124-34
pubmed: 19389805
Cell. 2004 Aug 20;118(4):517-28
pubmed: 15315763
Stem Cell Reports. 2015 Jun 3;:
pubmed: 26050928
Development. 2012 Feb;139(3):465-74
pubmed: 22190642
Mol Cell Biol. 2009 Dec;29(23):6294-308
pubmed: 19805521
Infect Immun. 2015 Jan;83(1):138-45
pubmed: 25312952
Cancer Res. 1999 Jun 15;59(12):2965-70
pubmed: 10383162
Dev Biol. 2010 Mar 1;339(1):155-65
pubmed: 20043902
Dev Cell. 2010 Nov 16;19(5):713-26
pubmed: 21074721
Cell Rep. 2013 Apr 25;3(4):1128-39
pubmed: 23545496
Physiol Genomics. 2006 Oct 11;27(2):141-55
pubmed: 16868071
Genes Dev. 2018 Nov 1;32(21-22):1430-1442
pubmed: 30366903
Development. 1996 Mar;122(3):983-95
pubmed: 8631275
Development. 2002 May;129(10):2367-79
pubmed: 11973269
PLoS Comput Biol. 2014 Mar 27;10(3):e1003501
pubmed: 24675637
Cell Rep. 2013 Oct 31;5(2):421-32
pubmed: 24139799
Science. 1988 Oct 21;242(4877):405-11
pubmed: 3175662
Cell Mol Gastroenterol Hepatol. 2016 Jun 23;2(5):648-662.e8
pubmed: 28078320
Cell Stem Cell. 2009 Oct 2;5(4):420-33
pubmed: 19796622
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3665-70
pubmed: 21307310
Nature. 2017 Oct 26;550(7677):529-533
pubmed: 29019984
Nature. 1994 Oct 13;371(6498):606-9
pubmed: 7935793
Cell. 2005 Dec 2;123(5):917-29
pubmed: 16325584
Cell. 1987 Dec 24;51(6):987-1000
pubmed: 3690668
Genes Dev. 2017 Dec 1;31(23-24):2391-2404
pubmed: 29321178
Bioinformatics. 2018 Jun 1;34(11):1930-1933
pubmed: 29360936
Nat Protoc. 2011 Nov 10;6(12):1920-8
pubmed: 22082986
Curr Protoc Mol Biol. 2015 Jan 05;109:21.29.1-21.29.9
pubmed: 25559105
Cell. 2012 Nov 21;151(5):994-1004
pubmed: 23159369
Nat Biotechnol. 2005 Dec;23(12):1534-41
pubmed: 16258519
Gastroenterology. 2002 Mar;122(3):689-96
pubmed: 11875002
Nucleic Acids Res. 2017 Jun 2;45(10):5770-5784
pubmed: 28334816
Cell Rep. 2014 Mar 27;6(6):1046-1058
pubmed: 24613355
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Development. 2017 Mar 15;144(6):1045-1055
pubmed: 27927684
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
J Biol Chem. 2015 Jan 16;290(3):1850-60
pubmed: 25488664
Nat Med. 2008 Aug;14(8):828-36
pubmed: 18660816
Nat Cell Biol. 2017 Nov;19(11):1326-1335
pubmed: 29058719
Nature. 1997 Mar 6;386(6620):84-7
pubmed: 9052785
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W187-91
pubmed: 24799436
Development. 2000 Apr;127(8):1563-72
pubmed: 10725233
Cell Stem Cell. 2015 Apr 2;16(4):386-99
pubmed: 25842977
Development. 2008 Mar;135(6):1049-58
pubmed: 18256198
Development. 2016 Jun 1;143(11):1833-7
pubmed: 27246709
PLoS One. 2011 Apr 06;6(4):e18280
pubmed: 21494671
Nat Commun. 2014 Dec 11;5:5728
pubmed: 25500896
Cell. 1993 Oct 22;75(2):387-98
pubmed: 8402920
Mol Cell Biol. 2013 Jan;33(2):281-92
pubmed: 23129810
Nature. 2005 Jun 16;435(7044):944-7
pubmed: 15959514
Dev Cell. 2009 Oct;17(4):516-26
pubmed: 19853565
Mol Cell Biol. 2011 May;31(10):2026-39
pubmed: 21402776
FEBS Lett. 2008 Jul 23;582(17):2555-60
pubmed: 18577384
Dev Biol. 2012 Mar 15;363(2):426-37
pubmed: 22285812
Dev Cell. 2009 Apr;16(4):588-99
pubmed: 19386267
Development. 2005 May;132(9):2093-102
pubmed: 15788452
Nature. 2011 Feb 3;470(7332):105-9
pubmed: 21151107

Auteurs

Namit Kumar (N)

Rutgers, the State University of New Jersey, Department of Genetics, Piscataway, NJ 08854, USA.
Cancer Institute of New Jersey, and Human Genetics Institute of New Jersey, Piscataway, NJ 08854, USA.

Yu-Hwai Tsai (YH)

Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

Lei Chen (L)

Rutgers, the State University of New Jersey, Department of Genetics, Piscataway, NJ 08854, USA.
Cancer Institute of New Jersey, and Human Genetics Institute of New Jersey, Piscataway, NJ 08854, USA.

Anbo Zhou (A)

Rutgers, the State University of New Jersey, Department of Genetics, Piscataway, NJ 08854, USA.
Cancer Institute of New Jersey, and Human Genetics Institute of New Jersey, Piscataway, NJ 08854, USA.

Kushal K Banerjee (KK)

Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA.
Harvard Stem Cell Institute, Cambridge, MA 02139, USA.

Madhurima Saxena (M)

Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA.
Harvard Stem Cell Institute, Cambridge, MA 02139, USA.

Sha Huang (S)

Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

Natalie H Toke (NH)

Rutgers, the State University of New Jersey, Department of Genetics, Piscataway, NJ 08854, USA.
Cancer Institute of New Jersey, and Human Genetics Institute of New Jersey, Piscataway, NJ 08854, USA.

Jinchuan Xing (J)

Rutgers, the State University of New Jersey, Department of Genetics, Piscataway, NJ 08854, USA.
Cancer Institute of New Jersey, and Human Genetics Institute of New Jersey, Piscataway, NJ 08854, USA.

Ramesh A Shivdasani (RA)

Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA.
Harvard Stem Cell Institute, Cambridge, MA 02139, USA.

Jason R Spence (JR)

Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA spencejr@med.umich.edu Verzi@biology.rutgers.edu.
Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, USA.
Center for Organogenesis, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Department of Biomedical Engineering, University of Michigan College of Engineering, Ann Arbor, MI 48109, USA.

Michael P Verzi (MP)

Rutgers, the State University of New Jersey, Department of Genetics, Piscataway, NJ 08854, USA spencejr@med.umich.edu Verzi@biology.rutgers.edu.
Cancer Institute of New Jersey, and Human Genetics Institute of New Jersey, Piscataway, NJ 08854, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH